Literature DB >> 12547543

Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis.

Alexander Woywodt1, Frank Streiber, Kirsten de Groot, Heide Regelsberger, Hermann Haller, Marion Haubitz.   

Abstract

BACKGROUND: Histological findings in small-vessel vasculitis associated with antineutrophil cytoplasmic antibodies (ANCAs) suggest that damaged endothelial cells undergo necrosis and detachment from the basement membrane. We postulated that isolation of these cells from peripheral blood might provide a novel marker of the disease and elucidate pathogenetic events.
METHODS: 18 patients with active ANCA-associated vasculitis, 20 patients in remission, 20 healthy controls, 12 patients with infection, and 12 patients with glomerular disease not associated with ANCA were studied. Endothelial cells were isolated from peripheral blood by use of Dynabeads coated with antibodies against CD146, and were stained for von Willebrand factor (vWF), CD31, and Ulex Europaeus lectin 1 (UEA-1). Tissue-factor immunocytochemistry and assays for markers of apoptosis and necrosis were also done.
FINDINGS: Few circulating endothelial cells were seen in healthy controls (0-20 cells/mL, median 5 cells/mL), patients with infection (0-16 cells/mL, median 8 cells/mL), and patients with non-ANCA glomerulonephritis (0-21 cells/mL, median 4 cells/mL). By contrast, large numbers of circulating endothelial cells were detected in patients with active vasculitis (20-5700 cells/mL, median 136 cells/mL, p<0.0001 when compared with healthy controls). Cell numbers fell substantially during 6 months of successful immunosuppressive treatment among those with active disease. Patients in remission had moderately raised cell numbers (0-60 cells/mL, median 16 cells/mL). 84% of cells obtained from patients with active disease stained positive for annexin/propidium iodide and 86% stained tissue factor positive, indicating a necrotic and procoagulant phenotype.
INTERPRETATION: Circulating endothelial cells are a novel marker of active ANCA-associated small-vessel vasculitis. The clinical use of this tool and the pathogenic mechanisms leading to these findings require further investigation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12547543     DOI: 10.1016/S0140-6736(03)12269-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  56 in total

1.  Inhibition of neutrophil-mediated production of reactive oxygen species (ROS) by endothelial cells is not impaired in anti-neutrophil cytoplasmic autoantibodies (ANCA)-associated vasculitis patients.

Authors:  F Al Laham; A-I Kälsch; L Heinrich; R Birck; C G M Kallenberg; P Heeringa; B Yard
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

Review 2.  Endothelial cells, antineutrophil cytoplasmic antibodies, and cytokines in the pathogenesis of systemic vasculitis.

Authors:  Maria C Cid; Marta Segarra; Ana García-Martínez; Jose Hernández-Rodríguez
Journal:  Curr Rheumatol Rep       Date:  2004-06       Impact factor: 4.592

3.  Circulating endothelial cells in relapse and limited granulomatous disease due to ANCA associated vasculitis.

Authors:  A Woywodt; C Goldberg; T Kirsch; K de Groot; U Erdbruegger; H Haller; M Haubitz
Journal:  Ann Rheum Dis       Date:  2005-09-08       Impact factor: 19.103

4.  Temporal and venepuncture-related decline in circulating endothelial cell capture from mixed venous blood.

Authors:  Christopher J Boos; Deirdre A Lane; Delene Kang; Patrick K Y Goon; Andrew D Blann; Gregory Y H Lip
Journal:  J Thromb Thrombolysis       Date:  2006-10       Impact factor: 2.300

Review 5.  Laboratory investigation in the diagnosis of vasculitis.

Authors:  Luis Felipe Flores-Suárez
Journal:  Curr Rheumatol Rep       Date:  2009-12       Impact factor: 4.592

Review 6.  Understanding endothelial cell apoptosis: what can the transcriptome, glycome and proteome reveal?

Authors:  Muna Affara; Benjamin Dunmore; Christopher Savoie; Seiya Imoto; Yoshinori Tamada; Hiromitsu Araki; D Stephen Charnock-Jones; Satoru Miyano; Cristin Print
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-08-29       Impact factor: 6.237

7.  Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Marion Haubitz; David M Good; Alexander Woywodt; Hermann Haller; Harald Rupprecht; Dan Theodorescu; Mohammed Dakna; Joshua J Coon; Harald Mischak
Journal:  Mol Cell Proteomics       Date:  2009-06-28       Impact factor: 5.911

Review 8.  Endothelium-neutrophil interactions in ANCA-associated diseases.

Authors:  Lise Halbwachs; Philippe Lesavre
Journal:  J Am Soc Nephrol       Date:  2012-09       Impact factor: 10.121

Review 9.  Thromboembolic disease in vasculitis.

Authors:  Gunnar Tomasson; Paul A Monach; Peter A Merkel
Journal:  Curr Opin Rheumatol       Date:  2009-01       Impact factor: 5.006

10.  Endothelial injury in childhood stroke with cerebral arteriopathy: a cross-sectional study.

Authors:  Despina Eleftheriou; Vijeya Ganesan; Ying Hong; Nigel J Klein; Paul A Brogan
Journal:  Neurology       Date:  2012-10-17       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.